Figure 4.
Comparison between XOIs and non-XOIs/placebo in MACE with high CV risk (A), in CVE with high CV risk (B). CV: Cardiovascular; CVE: Cardiovascular events; MACE: Major adverse cardiovascular events; XOIs: Xanthine oxidase inhibitors.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.